An interventional study of Monofocal IOL and Multifocal IOL in Cataract, sponsored by Aston University. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-01-21.
Sponsored by Aston University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 39 studies in Cataract with a site in United Kingdom — 8 open to participants now, 8 under way, 1 of them phase 3. Cataract · United Kingdom.
Among the 39 studies in Cataract with a site in United Kingdom, this one is the 2nd largest by planned enrollment of the 29 interventional ones that give a count, is one of 3 that started in 2013, is one of 23 with no phase, and was the 4th registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →8 of the 39 studies in Cataract with a site in United Kingdom are open now. Recruiting first, the newest first:
Carl Zeiss Meditec AG · Sites in United Kingdom, Czechia, Germany and 1 more country
Ages 18+
Alcon Research · Sites in United Kingdom
Ages 18+
Queen's University, Belfast · Sites in United Kingdom
Ages 50+
Vision Care Collective Limited · Sites in United Kingdom
Ages 18+
University of Plymouth · Sites in United Kingdom
Ages 50–75
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 40 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2013.
This study's planned enrollment of 500 is above the median of 79 across 1,094 interventional studies indexed under Cataract.
Median enrollment 100 across the 29 interventional studies, 157 across the 10 observational. Of the 20 that completed or were terminated, 7 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 39 have an industry lead sponsor. The 10 most frequent:
Aston University is the lead sponsor of 27 studies on the registry; 8 are open to participants now.
Aston University has 1 study filed under Cataract — fewer than ten, so there is no comparison to draw.
1 of the studies in Cataract with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07228091Alcon ResearchSurgical Procedure Efficiency Evaluation stuDy | 2027-06 |
Add it to your calendar (.ics) → With an account.
Among the 39 studies in Cataract with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main objective of this research is to assess visual function and optical performance of CE marked, implanted intraocular lenses to understand the individual factors that affect their performance and how these may be improved in future designs and to evaluate measurement techniques.
All outcome measures will be captured 3-6 months after surgery
A cataract occurs when the natural lens of the eye, which plays a major role in the focusing of light and production of sharp visual images, becomes cloudy and hardens, resulting in a loss of visual function. Left untreated, cataracts can cause preventable blindness. During cataract surgery the natural lens is removed and a man-made intraocular lens (IOL) is implanted in its place.
IOL technology has advanced significantly in recent years and as a result the main goal of cataract surgery is no longer simply the successful removal of the cloudy lens and restoration of vision. Providing patients with the best possible refractive outcome and the best possible visual quality is now much more important when assessing surgery outcomes.
Aspheric, multifocal and accommodating IOLs are among the new designs developed to improve visual outcome after cataract surgery. In order to assess the effectiveness of these designs, visual function needs to be evaluated both objectively and subjectively following their implantation. Such evaluation allows the continued evolution of these IOL designs towards optimum. This proposed research study, which aims to assess the visual function and optical performance of new CE marked IOLs after implantation, could significantly contribute to the enhancement and development of improved IOL designs in the future.
We have successfully conducted similar patient trials for the past 5 years. As new IOL designs are constantly being developed, approved and CE marked, this type of research study will always have the potential to offer new information that is not currently available and has not previously been assessed or published and could contribute towards improved IOL designs in the future.
All outcome measures will be captured 3-6 months after surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Monofocal IOL Implant Manufacturers of IOLs used as monofocal comparator are Alcon, AMO, Bausch and Lomb, Lenstec, Oculentis, Ophthec, Physiol and Zeiss
Procedure: Monofocal IOL
Multifocal IOL Manufacturers of multifocal IOLs under investigation are Alcon, AMO, Bausch and Lomb, Lenstec, Oculentis, Ophthec, Physiol and Zeiss
Procedure: Multifocal IOL
Toric IOL Manufacturers of toric IOLs under investigation are Alcon, AMO, Bausch and Lomb, Lenstec, Oculentis, Ophthec, Physiol and Zeiss
Procedure: Toric IOL
Monofocal Intraocular lens will be implanted
Also known as: Alcon AMO B&L Lenstec Oculentis Ophthec Physiol & Zeiss
Multifocal IOL will be implanted
Toric IOLS will be implanted
Unaided distance and near vision
Visual Acuity (logMAR)
Time frame: Measured at 3-6 months after surgery
Patient Satisfaction
NAVQ score
Time frame: Measured at 3-6 months after surgery
Residual refraction
Autorefraction / subjective refraction
Time frame: Measured at 3-6 months after surgery
Aberrations
Aberrometry
Time frame: Measured at 3-6 months after surgery
Corrected distance and near acuity
Acuity (logMAR)
Time frame: Measured at 3-6 months after surgery
Plan to share: Yes — Data collaboration will be considered on request
No publications or documents are linked to this record.
Started Sep 2013 (actual). Primary completion is estimated for Nov 2030, 206 months after the start.
Of 304 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 206 months is above that.
Counting every sponsor, half of 494 studies reached it within 17 months; a quarter within 9 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aston University